Listen: Biotech’s monkey shortage, the broken generics market, & conference cancel culture
What happened to the market for monkeys? Are some drugs too cheap? And why are biotech stocks still in the tank?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We explain how biotech is affected by a bizarre situation involving smuggled monkeys, international intrigue, and a criminal investigation. We also discuss what leads to generic drug shortages, whether every major pharmaceutical firm needs a weight-loss drug, and what it means when drug company cancels a conference appearance.
